EPAM vs REPL · P/E 14, rev $4.73B vs $825.7M cap
EPAM Systems Inc (EPAM) versus Replimune Group Inc (REPL) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Replimune Group Inc (REPL) is a biotechnology company listed on NASDAQ.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
REPL does not have a complete income-statement cache yet.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. REPL currently screens at market cap $825.7M.
Not investment advice. Open the EPAM and REPL stock pages for the full models.
Not investment advice.